A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer

Study ID
NCT01801904

Study type
Interventional

Study phase
Phase 2

Study status
Active, not recruiting

Trial Acronym

PACER

Trial Summary

The purpose of this study is to assess if panitumumab is active enough to warrant comparative studies in patients with metastatic colorectal cancer that has progressed after treatment with cetuximab.

More informations

Trial Starting Date

Dec 31,2012

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit